ClinicalTrials.gg
Not yet recruitingNCT07926243Updated Nov 9, 2026

"My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South)

An interventional study of MyHP-South Program in Multiple Chronic Conditions and Shared Decision-making, sponsored by University of Alabama at Birmingham. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Health services research

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate the feasibility and acceptability of the revised My Health Priorities (MyHP) program among rural and underserved older adults with multiple chronic conditions in the Deep South. The program is designed to help participants clarify their health-related values, as well as improve communication with family caregivers and healthcare providers to support medical decision-making. The main question this study aims to answer is whether the revised MyHP program is practical/easy for individuals to use, and if it helps support necessary conversations about healthcare priorities. Participants will be asked to complete the revised MyHP program over a Zoom or in-person session with their caregiver, as well as complete questionnaires over a telephone interview before and 12 weeks after the completion of the program. In addition to participating in the MyHP program, caregivers will also be asked to complete a series of questionnaires over a telephone interview before and 12 weeks after the program. Both patients and caregivers will also be asked to complete a brief survey about their experience with the program over a telephone interview.

02

Conditions studied

  • Multiple Chronic Conditions
  • Shared Decision-making

Keywords

  • Medical Decision-Making
  • Older Adults (65 years and older)
  • Health Communication
  • Healthcare Priorities
  • Rural Residence
  • Underserved Communities
  • Care Coordination
  • Caregiver
03

In context

Multiple Chronic Conditions

89 studies on the registry are indexed under Multiple Chronic Conditions; 16 are open to participants now.

This study's planned enrollment of 44 is below the median of 128 across 71 interventional studies indexed under Multiple Chronic Conditions.

Browse Multiple Chronic Conditions studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,421 studies on the registry; 277 are open to participants now.

Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for Patients:

  1. Identifies as African American or White/Caucasian
  2. Is 65 years of age or older
  3. Has at least two of the following chronic conditions: cancer, heart disease, kidney disease, liver disease, or lung disease
  4. English-speaking and able to complete baseline study measures
  5. Cognitively able to participate in decision-making discussions
  6. Has a family caregiver that meets the eligibility requirements
  7. Has reliable telephone access

Inclusion Criteria for Caregivers:

  1. Identifies as African American or White/Caucasian
  2. Is 18 years of age or older
  3. A relative, partner, or friend who provides unpaid assistance or support with health-related decision-making (may or may not live in the same residence)
  4. English-speaking and able to complete baseline study measures
  5. Cognitively able to participate in decision-making discussions
  6. Has reliable telephone access

Exclusion Criteria for Patients:

  1. Has a documented diagnosis of dementia
  2. Is unable to understand the study and provide
  3. Resides in a nursing home or assisted living facility

Exclusion Criteria for Caregivers:

  1. Is unable to understand the study and provide informed consent
  2. Is unable to communicate with research staff
  3. Is unable to participate in the dyadic MyHP-South session and required assessments
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    MyHP-South Users

    Includes the patients and caregivers who will be utilizing the MyHP-South program, as well as evaluating its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. This arm also includes the clinicians who will be assessing the usefulness of the program in a primary care setting.

    Other: MyHP-South Program

Interventions

  • OtherMyHP-South Program

    Participants will use the refined My Health Priorities South (MyHP-South) program to help identify and communicate personal health priorities, then evaluate its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery.

06

What researchers measure

Primary outcomes

  1. Patient System Usability Scale (SUS)

    Over a Zoom or telephone interview, patients will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree.

    Time frame: At the MyHP-South session, within 14 days after baseline.

  2. Acceptability Interview

    Over a Zoom or telephone interview, both patients and caregivers will together answer 26 questions regarding their experience using the revised MyHP-South tool. Answer options will be open-ended.

    Time frame: At the MyHP-South session, within 14 days after baseline.

  3. Recruitment Feasibility

    Indicated by the number and proportion of eligible patient-caregiver dyads who enroll.

    Time frame: From initiation of recruitment through enrollment of the final dyad (approximately 12 months).

  4. Retention and Completion Feasibility

    Indicated by the number and proportion of enrolled dyads completing baseline assessments, the MyHP-South session, immediate post-session assessments, the acceptability interview, and the 12-week assessments.

    Time frame: From baseline through 12 weeks after the MyHP-South session.

  5. Caregiver System Usability Scale (SUS)

    Over a Zoom or telephone interview, caregivers will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree.

    Time frame: Immediately after the MyHP-South session, during the same study visit.

Secondary outcomes

  1. CollaboRATE Scale Score

    Over a telephone interview, patients will answer three questions regarding their experience with their healthcare provider during a clinical encounter. Answer options will follow a ranked scale ranging from zero to nine and will then be calculated into a final score/percentage.

    Time frame: At baseline and 12 weeks after the MyHP-South session.

  2. Treatment Burden Questionnaire (TBQ) Score

    Over a telephone interview, patients will answer 13 questions regarding the potential burden of managing multiple chronic conditions. Answer options will follow a ranked scale ranging from zero to ten and will then be calculated into a final score.

    Time frame: At baseline and 12 weeks after the MyHP-South session.

  3. Patient Shared Care Instrument Score

    Over a telephone interview, patients will answer 19 questions regarding communication, decision making, and reciprocity with their caregiver. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales.

    Time frame: At baseline and 12 weeks after the MyHP-South session.

  4. Bakas Caregiver Outcomes Scale (BCOS)

    Over a telephone interview, caregivers will answer 10 questions regarding potential life changes that have occurred as a result of serving as a caregiver. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from -3: changed for the worse, to +3: changed for the best.

    Time frame: At baseline and 12 weeks after the MyHP-South session.

  5. Older Patient Assessment of Chronic Illness Care (O-PACIC) Scale Score

    Over a telephone interview, patients will answer ten questions regarding the quality of medical care they have received over the past six months. Answer options will follow a Likert-type frequency scale, which will then be calculated into a final score.

    Time frame: At baseline and 12 weeks after the MyHP-South session.

  6. Caregiver Shared Care Instrument Score

    Over a telephone interview, caregivers will answer 19 questions regarding communication, decision making, and reciprocity with their patient. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales.

    Time frame: At baseline and 12 weeks after the MyHP-South session.

Other outcomes

  1. Timing Log for MyHP-South Session

    Research staff will document the length of each MyHP-South session by documenting what time the session started and what time the session ended. Time used to navigate technical difficulties will be subtracted. Tracking how long the session takes serves as a measure of feasibility.

    Time frame: At the MyHP-South session, within 14 days after baseline.

  2. Clinician Feedback Survey

    Over an electronic survey, clinicians who provide care to enrolled patients will answer ten questions regarding the clarity, fit, and usefulness of the revised MyHP-South in a primary care setting.

    Time frame: Within 6 months after the completion of the MyHP-South session.

07

Study locations

1 site
  • The Whitaker Clinic of the University of Alabama at Birmingham (UAB) Hospital
    Birmingham, Alabama 35233, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926243
Responsible party
Deborah Ejem (Associate Professor, University of Alabama at Birmingham) — Principal investigator
First posted
Nov 9, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Alexis M Johnson, B.S.
Contact
amjohns2@uab.edu
205-975-1864
Deborah B Ejem, Ph.D.
Contact
tejem@uab.edu
205-996-1671
Deborah B Ejem, Ph.D.
principal investigator · University of Alabama at Birmingham

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion